NCT05526027 Real-world Efficacy and Safety of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Therapy in Adult Patients With Cystic Fibrosis (CF) Status UNKNOWN Phase NA
NCT05519020 Inhaled Therapy Adherence and Outcomes to Kaftrio in Cystic Fibrosis Status COMPLETED Phase N/A
NCT05515250 Neuromodulation for Children With Cystic Fibrosis Experiencing Chronic Abdominal Pain Status TERMINATED Phase NA
NCT05504837 A Study Assessing KB407 for the Treatment of Cystic Fibrosis Status RECRUITING Phase PHASE1
NCT05482048 Pilot Trial of ExACT (Exercise as Airway Clearance Therapy) for People With Cystic Fibrosis Status ACTIVE_NOT_RECRUITING Phase NA
NCT05481190 The Impact Of A Tele-Exercise Program For Children With Cystic Fibrosis During The Covid-19 Pandemic On Quality Of Life Status COMPLETED Phase NA
NCT05455671 Real-Time Assessment of Lung Structure and Function in Children and Young Adults With CF Using Electrical Impedance Tomography Status COMPLETED Phase N/A
NCT05453578 A Phase 1b/2 Trial of the Safety and Microbiological Activity of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa Status COMPLETED Phase PHASE1/PHASE2
NCT05444257 A Study Evaluating the Long-term Safety and Efficacy of VX-121 Combination Therapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05437120 Pharmacokinetics and Safety Assessment of VX-121/Tezacaftor/Deutivacaftor in Participants With Moderate Hepatic Impairment Status COMPLETED Phase PHASE1
NCT05422222 Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age Status RECRUITING Phase PHASE3
NCT05420844 Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic Fibrosis Status COMPLETED Phase NA
NCT05408910 Rifaximin for Treatment of Bloating in Children and Adults With Cystic Fibrosis Status WITHDRAWN Phase PHASE2/PHASE3
NCT05392855 Symptom Based Performance of Airway Clearance After Starting Highly Effective Modulators for Cystic Fibrosis (SPACE-CF) Status TERMINATED Phase NA
NCT05377502 Performance and Patient Acceptance of a Commercially Available Beverage as Compared to an Oral Glucose Solution for Oral Glucose Tolerance Tests in Cystic Fibrosis (CF) Patients Who Are Screened for CF-related Diabetes. Status UNKNOWN Phase N/A
NCT05331183 Study to Evaluate Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) Long-term Safety and Efficacy in Subjects Without F508del Status ACTIVE_NOT_RECRUITING Phase PHASE3